Sana Biotechnology Inc SANA:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
Last | 05/06/24 EDT
10.00quote price arrow down-0.44 (-4.21%)
Volume
1,712,840
52 week range
2.74 - 12.00
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close10.00
  • 52 Week High12.00
  • 52 Week High Date03/01/24
  • 52 Week Low2.74
  • 52 Week Low Date10/27/23

Key Stats

  • Market Cap2.213B
  • Shares Out221.32M
  • 10 Day Average Volume1.85M
  • Dividend-
  • Dividend Yield-
  • Beta1.82
  • YTD % Change145.1

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close10.00
  • 52 Week High12.00
  • 52 Week High Date03/01/24
  • 52 Week Low2.74
  • 52 Week Low Date10/27/23
  • Market Cap2.213B
  • Shares Out221.32M
  • 10 Day Average Volume1.85M
  • Dividend-
  • Dividend Yield-
  • Beta1.82
  • YTD % Change145.1

RATIOS/PROFITABILITY

  • EPS (TTM)-1.46
  • P/E (TTM)-6.83
  • Fwd P/E (NTM)-8.49
  • EBITDA (TTM)-268.495M
  • ROE (TTM)-72.00%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/01/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Sana Biotechnology Inc

 

Profile

MORE
Sana Biotechnology, Inc. is a biotechnology company focusing on utilizing engineered cells as medicines. It is engaged in developing cell engineering programs to revolutionize treatment across an array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune and central nervous system disorders. It develops a pipeline of clinical product candidates focused on creating transformative ex vivo therapies across a range of...
Richard Mulligan Ph.D.
Vice Chairman of the Board and Head of SanaX
Hans Bishop
Independent Chairman of the Board
Steven Harr M.D.
President, Chief Executive Officer, Director
Nathan Hardy
Chief Financial Officer, Executive Vice President
Bernard Cassidy
Executive Vice President, General Counsel, Company Secretary
Address
188 East Blaine Street, Suite 400
Seattle, WA
98102
United States

Top Peers

SYMBOLLASTCHG%CHG
RCKT
Rocket Pharmaceuticals Inc
23.20-0.27-1.15%
FUSN
Fusion Pharmaceuticals Inc
21.42-0.03-0.14%
SNDX
Syndax Pharmaceuticals Inc
22.50+0.45+2.04%
INBX
Inhibrx Inc
34.30+0.15+0.44%
KROS
Keros Therapeutics Inc
60.26-0.31-0.51%